Scientists develop a quick, cheap and portable test for diagnosing tuberculosis

May 17, 2017
This photomicrograph reveals Mycobacterium tuberculosis bacteria using acid-fast Ziehl-Neelsen stain; Magnified 1000 X. The acid-fast stains depend on the ability of mycobacteria to retain dye when treated with mineral acid or an acid-alcohol solution such as the Ziehl-Neelsen, or the Kinyoun stains that are carbolfuchsin methods specific for M. tuberculosis. Credit: public domain

A microchip-based test developed by A*STAR researchers can diagnose tuberculosis in 15 minutes. The test meets the speed, cost, accessibility and disposal standards recommended by the World Health Organization for detecting the deadly disease.

Tuberculosis is caused by the bacterium Mycobacterium . In 2015, the disease killed almost 2 million people, and infected more than 10 million, of which about 35 to 40 per cent went undiagnosed—a dangerous scenario given its contagious nature, spreading when people with active forms of the disease cough or sneeze into the air.

The most common diagnostic used in the developing world is 100 years old, and involves looking at sputum samples under a microscope. It only detects up to 60 per cent of positive cases (a measure of sensitivity), and cannot confirm negative cases (specificity).

Alternative tests require very expensive equipment and skilled technicians, or take too long. "In the developing world, the current gold-standard point-of-care test is still sputum microscopy," says Amit Singhal, who led the study at the A*STAR Singapore Immunology Network.

In recent years, several point-of-care tests have entered the market. These detect infection based on whether patients have developed antibodies against proteins secreted by the pathogen. They are cheap, quick and simple, but no more effective than the sputum method. Singhal wanted to improve the sensitivity and specificity of these techniques by instead looking for antibodies against lipids found on the surface of the .

His team sprinkled the bacterial lipids on magnetic beads and anchored the beads to one end of a microchip with six chambers for processing blood samples. Any antibodies present in the blood would latch on to the lipids and could then be tagged with a color-changing molecule. The lipid test offered much better results than the protein test, or any –protein combinations. Assessing 146 samples, including 41 healthy controls, it detected 72 per cent of active tuberculosis cases, increasing to 90 per cent when combined with the sputum test—all within 15 minutes.

Singhal estimates that the microchips could be mass-produced for less than US$10, and their small size makes them easy to dispose of underground. He plans to further automate the device to light up with a color that can be measured using a smartphone. Singhal also wants to boost the test's sensitivity, and find ways of detecting tuberculosis at a latent stage, before it becomes contagious.

"One-third of the world has latent , of which 5 to 10 per cent develop ," says Singhal. "The plan is to identify those people very early in the infection process."

Explore further: Blood test could transform tuberculosis diagnosis, treatment in developing countries

More information: Vigneshwaran Mani et al. Microchip-based ultrafast serodiagnostic assay for tuberculosis, Scientific Reports (2016). DOI: 10.1038/srep35845

Related Stories

Blood test could transform tuberculosis diagnosis, treatment in developing countries

February 19, 2016
A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year.

An oral antidiabetic drug shows promise for treating tuberculosis

June 24, 2015
The drug metformin, already used in the USA to treat type 2 diabetes, also enhances the body's immune response to tuberculosis, according to A*STAR researchers.

New tuberculosis blood test in children is reliable and highly specific

August 31, 2014
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active ...

A simple diagnostic test to detect tuberculosis in humans

May 29, 2015
Tuberculosis (TB) represents a growing worldwide healthcare burden. Second only to HIV in terms of its global impact, TB infected 8.5 million people and caused 1.4 million deaths in 2011. If these statistics are to improve, ...

Tuberculosis and HIV co-infection

October 18, 2016
The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system. This is the conclusion of a study carried out by researchers at Linköping University in Sweden. ...

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.